[Detection of the first recurrence in patients with melanoma: three quarters by the patient, one quarter during outpatient follow-up]
- PMID: 18402322
[Detection of the first recurrence in patients with melanoma: three quarters by the patient, one quarter during outpatient follow-up]
Abstract
Objective: To evaluate the benefit of frequent outpatient follow-up after the initial diagnosis and treatment of melanoma.
Design: Retrospective study.
Method: Patients from the Groningen University Medical Centre with a first recurrence ofa previously treated primary melanoma (American Joint Committee on Cancer stage I-III) were interviewed to determine how many of them had detected the recurrence themselves. Patient data and recurrence characteristics were compared with data from a previous Australian study in order to evaluate the differences between the Dutch and the Australian population.
Results: 70 patients with a first recurrence of melanoma were studied. Of the 70 first recurrences, 53 (76%) had been detected by the patient; 10% of the patients had a sign or symptom, but did not detect the recurrence themselves; 11% of the first recurrences were detected as a consequence of self-examination. The proportion of detection by the patient versus detection by a doctor was roughly equal in the Dutch and Australian populations.
Conclusion: Three quarters of the first recurrences of a treated melanoma had been detected by the patients themselves, the largest number by accident and only 11% by self-examination. It is not likely that the continuation of frequent follow-up visits will contribute to the detection of recurrences. These findings are no different from the results in the Australian population.
Comment in
-
[The value of follow-up in surgical oncology].Ned Tijdschr Geneeskd. 2008 Mar 8;152(10):538-40. Ned Tijdschr Geneeskd. 2008. PMID: 18402316 Dutch.
-
[Detection of the first recurrence in patients with melanoma: three quarters by the patient, one quarter during outpatient follow-up].Ned Tijdschr Geneeskd. 2008 Jul 5;152(27):1546-7; author reply 1547. Ned Tijdschr Geneeskd. 2008. PMID: 18681367 Dutch. No abstract available.
Similar articles
-
Detection of first relapse in cutaneous melanoma patients: implications for the formulation of evidence-based follow-up guidelines.Ann Surg Oncol. 2007 Jun;14(6):1924-33. doi: 10.1245/s10434-007-9347-2. Epub 2007 Mar 15. Ann Surg Oncol. 2007. PMID: 17357855
-
Method of detection of initial recurrence of stage II/III cutaneous melanoma: analysis of the utility of follow-up staging.Ann Surg Oncol. 2009 Apr;16(4):941-7. doi: 10.1245/s10434-008-0238-y. Epub 2008 Dec 20. Ann Surg Oncol. 2009. PMID: 19101766
-
Follow-up recommendations for patients with American Joint Committee on Cancer Stages I-III malignant melanoma.Cancer. 1999 Dec 1;86(11):2252-8. Cancer. 1999. PMID: 10590365
-
Staging work-up and post-treatment surveillance of patients with melanoma.Clin Plast Surg. 2000 Jul;27(3):377-90, viii. Clin Plast Surg. 2000. PMID: 10941559 Review.
-
[Late recurrence of melanoma beyond 10 years].Ann Dermatol Venereol. 1994;121(6-7):454-8. Ann Dermatol Venereol. 1994. PMID: 7702277 Review. French.
Cited by
-
Detection of melanoma nodal metastases; differences in detection between elderly and younger patients do not affect survival.Ann Surg Oncol. 2010 Nov;17(11):3008-14. doi: 10.1245/s10434-010-1085-1. Epub 2010 May 5. Ann Surg Oncol. 2010. PMID: 20443146 Free PMC article.
-
Barriers and facilitators of adherence to medical advice on skin self-examination during melanoma follow-up care.BMC Dermatol. 2013 Mar 1;13:3. doi: 10.1186/1471-5945-13-3. BMC Dermatol. 2013. PMID: 23448249 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Medical